Screening inhibitory effects of selected flavonoids on human recombinant aldose reductase enzyme: in vitro and in silico study

References

• Adem, S., et al., 2014. Investigation of the effects of some phenolic compounds on the activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from human erythrocytes. Journal of biochemical and molecular toxicology, 28 (11), 510–514.
   PubMed Web of Science ®Google Scholar
• Akileshwari, C., et al., 2012. Inhibition of aldose reductase by Gentiana lutea extracts. Experimental diabetes research, 2012, 147965.
   PubMedGoogle Scholar
• Akileshwari, C., et al., 2014. Bioflavonoid ellagic acid inhibits aldose reductase: Implications for prevention of diabetic complications. Journal of functional foods, 6, 374–383.
   Web of Science ®Google Scholar
• Alim, Z., et al., 2017. Inhibition behaviours of some phenolic acids on rat kidney aldose reductase enzyme: an in vitro study. Journal of enzyme inhibition and medicinal chemistry, 32 (1), 277–284.
   PubMed Web of Science ®Google Scholar
• Androutsopoulos, V.P., et al., 2010. Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes. Pharmacology & therapeutics, 126 (1), 9–20.
   PubMed Web of Science ®Google Scholar
• Aslan, E. and Adem, S., 2015. Investigation of the effects of some drugs and phenolic compounds on human dihydrofolate reductase activity. Journal of biochemical and molecular toxicology, 29 (3), 135–139.
   PubMed Web of Science ®Google Scholar
• Aslan, E., Guler, C., and Adem, S., 2016. In vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2. Journal of enzyme inhibition and medicinal chemistry, 31 (2), 314–317.
   PubMed Web of Science ®Google Scholar
• Balasuriya, B.N. and Rupasinghe, H.V., 2011. Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Functional foods in health and disease, 1, 172–188.
   Google Scholar
• Brownlee, M., 1992. Glycation products and the pathogenesis of diabetic complications. Diabetes care, 15 (12), 1835–1843.
   PubMed Web of Science ®Google Scholar
• Chalk, C., Benstead, T.J., and Moore, F., 2007. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane database of systematic reviews, (4), CD004572.
   PubMed Web of Science ®Google Scholar
• Chethan, S., Dharmesh, S.M., and Malleshi, N.G., 2008. Inhibition of aldose reductase7 from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols. Bioorganic & medicinal chemistry, 16 (23), 10085–10090.
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz, J.G., et al., 1986. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy. Diabetes, 35 (5), 574–578.
   PubMed Web of Science ®Google Scholar
• Demir, Y., et al., 2017. Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney. Journal of biochemical and molecular toxicology, 31 (9), e21936.
   Web of Science ®Google Scholar
• Demir, Y., et al., 2019a. Antidiabetic properties of dietary phenolic compounds: inhibition effects on α-amylase, aldose reductase, and α-glycosidase. Biotechnology and applied biochemistry, 66 (5), 781–786.
   PubMed Web of Science ®Google Scholar
• Demir, Y., et al., 2019b. Inhibition effects of quinones on aldose reductase: antidiabetic properties. Environmental toxicology and pharmacology, 70, 103195.
   PubMed Web of Science ®Google Scholar
• Dunlop, M., 2000. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney international, 58, S3–S12.
   Web of Science ®Google Scholar
• Elliott, A.J., et al., 1992. Inhibition of glutathione reductase by flavonoids: a structure-activity study. Biochemical pharmacology, 44 (8), 1603–1608.
   PubMed Web of Science ®Google Scholar
• Hamada, Y., et al., 1996. Role of polyol pathway in nonenzymatic glycation. Nephrology dialysis transplantation, 11 (supp5), 95–98.
   PubMedGoogle Scholar
• Harding, J., 1991. Cataract. Biochemistry epidemiology and pharmacology. 1st ed. London: Chapman & Hall.
   Google Scholar
• Israël, M. and Schwartz, L., 2011. On the metabolic origin of cancer: substances that target tumor metabolism. Biomedical research, 22, 132–166.
   Google Scholar
• Jeong, H.-J., et al., 1999. Inhibition of aromatase activity by flavonoids. Archives of pharmacal research, 22 (3), 309–312.
   PubMed Web of Science ®Google Scholar
• Jung, H.A., et al., 2011. Extraction and identification of three major aldose reductase inhibitors from Artemisia montana. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association, 49 (2), 376–384.
   PubMed Web of Science ®Google Scholar
• Kador, P.F., Kinoshita, J.H., and Sharpless, N.E., 1985. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. Journal of medicinal chemistry, 28 (7), 841–849.
   PubMed Web of Science ®Google Scholar
• Kinoshita, T., et al., 2002. The structure of human recombinant aldose reductase complexed with the potent inhibitor zenarestat. Acta crystallographica. Section D, biological crystallography, 58 (Pt 4), 622–626.
   PubMedGoogle Scholar
• Kinoshita, J.H. and Nishimura, C., 1988. The involvement of aldose reductase in diabetic complications. Diabetes/metabolism reviews, 4 (4), 323–337.
   PubMed Web of Science ®Google Scholar
• Kumar, S. and Pandey, A.K., 2013. Chemistry and biological activities of flavonoids: an overview. The scientific world journal, 2013, 1–16.
   Google Scholar
• Lee, J., et al., 2017. Determination of flavonoids from Perilla frutescens var. japonica seeds and their inhibitory effect on aldose reductase. Applied biological chemistry, 60 (2), 155–162.
   Web of Science ®Google Scholar
• Mathebula, S.D., 2015. Polyol pathway: a possible mechanism of diabetes complications in the eye. African vision and eye health, 74 (1), 5.
   Google Scholar
• Michael, R. and Bron, A., 2011. The ageing lens and cataract: a model of normal and pathological ageing. Philosophical transactions of the Royal Society B: biological sciences, 366 (1568), 1278–1292.
   PubMed Web of Science ®Google Scholar
• Molegro, A., 2019. MVD 7.0 Molegro Virtual Docker. Aarhus C, Denmark.
   Google Scholar
• Muthenna, P., Akileshwari, C., and Reddy, G.B., 2012. Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine. The biochemical journal, 442 (1), 221–230.
   PubMedGoogle Scholar
• Oguntibeju, O., 2013. Diabetes mellitus: insights and perspectives. InTech.
   Google Scholar
• Ottanà, R., et al., 2011. Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications. European journal of medicinal chemistry, 46 (7), 2797–2806.
   PubMed Web of Science ®Google Scholar
• Özaslan, M.S., et al., 2019. Inhibition effects of some antidepressant drugs on pentose phosphate pathway enzymes. Environmental toxicology and pharmacology, 72, 103244.
   PubMed Web of Science ®Google Scholar
• Patel, D., et al., 2012. Pharmacologically tested aldose reductase inhibitors isolated from plant sources – a concise report. Chinese journal of natural medicines, 10 (5), 388–400.
   Web of Science ®Google Scholar
• Patil, K.K. and Gacche, R.N., 2017. Inhibition of glycation and aldose reductase activity using dietary flavonoids: a lens organ culture studies. International journal of biological macromolecules, 98, 730–738.
   PubMed Web of Science ®Google Scholar
• Ramirez, M.A. and Borja, N.L., 2008. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy, 28 (5), 646–655.
   PubMed Web of Science ®Google Scholar
• Rao, A.R., Veeresham, C., and Asres, K., 2013. In vitro and in vivo inhibitory activities of four Indian medicinal plant extracts and their major components on rat aldose reductase and generation of advanced glycation endproducts. Phytotherapy research : PTR, 27 (5), 753–760.
   PubMed Web of Science ®Google Scholar
• Rawel, H.M., Meidtner, K., and Kroll, J., 2005. Binding of selected phenolic compounds to proteins. Journal of agricultural and food chemistry, 53 (10), 4228–4235.
   PubMed Web of Science ®Google Scholar
• Singh Grewal, A., et al., 2016. Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases. Mini reviews in medicinal chemistry, 16 (2), 120–162.
   PubMed Web of Science ®Google Scholar
• Srivastava, S.K., Ramana, K.V., and Bhatnagar, A., 2005. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocrine reviews, 26 (3), 380–392.
   PubMed Web of Science ®Google Scholar
• Tadera, K., et al., 2006. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. Journal of nutritional science and vitaminology, 52 (2), 149–153.
   PubMed Web of Science ®Google Scholar
• Türkeş, C., Demir, Y., and Beydemir, Ş., 2019. Anti-diabetic properties of calcium channel blockers: inhibition effects on aldose reductase enzyme activity. Applied biochemistry and biotechnology, 189 (1), 318–329.
   PubMed Web of Science ®Google Scholar
• Varma, S., Mikuni, I., and Kinoshita, J., 1975. Flavonoids as inhibitors of lens aldose reductase. Science (New York, N.Y.), 188 (4194), 1215–1216.
   PubMed Web of Science ®Google Scholar
• Veeresham, C., et al., 2013. In vitro and in vivo aldose reductase inhibitory activity of standardized extracts and the major constituent of Andrographis paniculata. Phytotherapy research : PTR, 27 (3), 412–416.
   PubMed Web of Science ®Google Scholar
• Wang, Q.-Q., et al., 2013. Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors. Bioorganic & medicinal chemistry, 21 (14), 4301–4310.
   PubMed Web of Science ®Google Scholar
• Whiting, D.R., et al., 2011. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes research and clinical practice, 94 (3), 311–321.
   PubMed Web of Science ®Google Scholar
• Xiao, J., et al., 2015. Advance in dietary polyphenols as aldose reductases inhibitors: structure-activity relationship aspect. Critical reviews in food science and nutrition, 55 (1), 16–31.
   PubMed Web of Science ®Google Scholar
• Yabe-Nishimura, C., 1998. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacological reviews, 50 (1), 21–34.
   PubMed Web of Science ®Google Scholar
• Yki‐Järvinen, H., 1998. Toxicity of hyperglycaemia in type 2 diabetes. Diabetes/metabolism reviews, 14 (S1), S45–S50.
   PubMedGoogle Scholar
• Ziegler, D., 2004. Polyneuropathy in the diabetic patient-update on pathogenesis and management. Nephrology, Dialysis, Transplantation: official Publication of the European Dialysis and Transplant Association – European Renal Association, 19 (9), 2170–2175.
   PubMed Web of Science ®Google Scholar